XML 20 R9.htm IDEA: XBRL DOCUMENT
v3.25.2

Cash, Cash Equivalents, Restricted Cash, and Investments | 6 Months Ended
--- | ---
Aug. 02, 2025
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract] |
Cash, Cash Equivalents, Restricted Cash, and Investments | Cash, Cash Equivalents, Restricted Cash, and Investments As of August 2, 2025 and February 1, 2025, cash and cash equivalents consist of cash and money market funds, and all highly liquid investments with an original or remaining maturity of 90 days or less when purchased. As of August 2, 2025 and February 1, 2025, short-term and long-term investments in marketable debt securities consist of U.S. government and agency securities, corporate notes and bonds, and commercial paper. Restricted cash as of August 2, 2025 and February 1, 2025 primarily consists of letters of credit secured as collateral on the Company’s office space leases. Total cash, cash equivalents, and restricted cash consist of the following (in thousands):
| As of
| August 2, 2025 |  | February 1, 2025
Cash and cash equivalents | $ | 258,472 |  |  | $ | 227,576 |
Restricted cash | 23,037 |  |  | 18,218 |
Total cash, cash equivalents, and restricted cash | $ | 281,509 |  |  | $ | 245,794 |
There were no material unrealized gains or losses for cash equivalents, either individually or in the aggregate, as of August 2, 2025 and February 1, 2025. The following is a summary of available-for-sale marketable debt securities recorded within short-term and long-term investments on the condensed consolidated balance sheets (in thousands):
| As of
| August 2, 2025
| Amortized Cost |  | Gross Unrealized Gains |  | Gross Unrealized Losses |  | Estimated Fair Value
Investments |  |  |  |  |  |  |
Commercial paper | $ | 115,140 |  |  | $ | — |  |  | $ | (1) |  |  | $ | 115,139 |
Corporate notes and bonds | 460,554 |  |  | 1,514 |  |  | (114) |  |  | 461,954 |
U.S. government and agency securities | 252,117 |  |  | 443 |  |  | (60) |  |  | 252,500 |
Total investments | $ | 827,811 |  |  | $ | 1,956 |  |  | $ | (174) |  |  | $ | 829,593 |
| As of
| February 1, 2025
| Amortized Cost |  | Gross Unrealized Gains |  | Gross Unrealized Losses |  | Estimated Fair Value
Investments |  |  |  |  |  |  |
Commercial paper | $ | 62,590 |  |  | $ | — |  |  | $ | — |  |  | $ | 62,590 |
Corporate notes and bonds | 444,360 |  |  | 814 |  |  | (437) |  |  | 444,737 |
U.S. government and agency securities | 242,517 |  |  | 283 |  |  | (253) |  |  | 242,547 |
Total investments | $ | 749,467 |  |  | $ | 1,097 |  |  | $ | (690) |  |  | $ | 749,874 |
The Company included $6.9 million and $6.2 million of accrued interest receivable in “Prepaid expenses and other current assets” on the condensed consolidated balance sheets as of August 2, 2025 and February 1, 2025, respectively. The Company did not recognize an allowance for credit losses against accrued interest receivable as of August 2, 2025 and February 1, 2025 because such potential losses were not material. For available-for-sale marketable debt securities with unrealized loss positions, the Company does not intend to sell any of the securities and the Company considers it more likely than not that the Company will hold these securities until a recovery of the cost basis, which may not occur until maturity. The Company did not recognize an allowance for credit losses on these securities as of August 2, 2025 and February 1, 2025 because such potential losses were not material. As of August 2, 2025, the estimated fair values of available-for-sale marketable debt securities, by remaining contractual maturity, are as follows (in thousands):
| As of
| August 2, 2025
Due within one year | $ | 443,327 |
Due in one year to three years | 386,266 |
Total | $ | 829,593 |
There were no material gains or losses that were reclassified out of accumulated other comprehensive income (loss), either individually or in the aggregate, during the three and six months ended August 2, 2025 and August 3, 2024. Concentrations of Credit Risk—The Company maintains its investments in marketable debt securities with high-quality financial institutions with investment-grade ratings.

X
- Definition The entire disclosure of cash, cash equivalent, and debt and equity securities, including realized and unrealized gain (loss). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 320 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/320/tableOfContent + Details
Name: | us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration